Malek Chamoun

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Montreal, Canada (Federal Level)
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Malek Chamoun
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Malek Chamoun

Form 4 holding 10%+ Owner

Sunshine Biopharma, Inc

Security class
Common Stock, par value $0.001 per share
Shares / value
3,700,000
Estimated value
$2,824,950
Report date
20 Oct 2022
Price
$0.7635
Ownership
Direct

Insider Reports Filed by Malek Chamoun

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .